Zobrazeno 1 - 10
of 41
pro vyhledávání: '"MASAHIRO HAMANOUE"'
Autor:
Yoshifumi Hidaka, Miyo Tomita, Ryosuke Desaki, Masahiro Hamanoue, Sonshin Takao, Mari Kirishima, Takao Ohtsuka
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-6 (2022)
Abstract Background The treatment of hepatocellular carcinoma (HCC) requires diverse and multidisciplinary approaches. In recent years, new agents with good antitumor effects have emerged for systemic chemotherapy, and conversion surgery (CS) after s
Externí odkaz:
https://doaj.org/article/94aad15f10ed4170b82ab35dac570542
Autor:
Yoshifumi Hidaka, Takaaki Arigami, Yusaku Osako, Ryosuke Desaki, Masahiro Hamanoue, Sonshin Takao, Mari Kirishima, Takao Ohtsuka
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-7 (2022)
Abstract Background Immune checkpoint inhibitors are reportedly effective in treating microsatellite instability (MSI)-high gastric cancer. There are a few case reports of conversion surgery (CS) with nivolumab but none with pembrolizumab. Herein, we
Externí odkaz:
https://doaj.org/article/c08a27244f8b4ddcb67d7b6ebff1bbd1
Autor:
Tomohiro Noguchi, Masahiro Hamanoue, Yuko Kijima, Shoji Natsugoe, Hiroshi Shirahama, Haruhi Fukuhisa
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 44:231-237
Autor:
Shigehiro Yanagita, Daisuke Matsushita, Shuichi Hokita, Shoji Natsugoe, Futoshi Miyazono, Masahiro Hamanoue, Saburo Nakashima, Keishi Okubo, Takaaki Arigami, Takashi Kijima, Takao Ohtsuka, Yoshikazu Uenosono
Publikováno v:
Cancer chemotherapy and pharmacology. 87(6)
The prognosis of metastatic gastric cancer has improved due to trastuzumab in patients with HER2 positive. Circulating tumor cells (CTCs) have been examined as a prognostic predictor in gastric cancer. The clinical advantage of trastuzumab was examin
Autor:
Hiroshi Imamura, Kousei Maemura, Yoshito Ogura, Shin‑Ichirou Mori, Kuniaki Aridome, Sumiya Ishigami, Shoji Natsugoe, Kouichi Kaneko, Futoshi Miyazono, Fumio Kijima, Masayuki Yanagi, Kouki Tokuda, Masahiro Hamanoue, Kenji Baba
Publikováno v:
Molecular and Clinical Oncology. 4:393-398
The present study aimed to study the efficacy of aprepitant in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy (MEC) for colorectal cancer (CRC), and comprised a multicenter,
Autor:
Hiroshi Saeki, Hironaga Satake, Yasunori Emi, Eiji Oki, Soichiro Maekawa, Koji Ando, Kenji Sakai, Mototsugu Shimokawa, Masahiro Hamanoue, Yoshihiko Maehara, Yoshito Akagi, Yasuo Sakamoto, Hideo Baba, Toyokuni Suenaga, Takayuki Shimose, Seiichiro Kai
Publikováno v:
International journal of clinical oncology. 22(5)
This study was designed to evaluate the efficacy and toxicity of XELIRI plus bevacizumab for the treatment of Japanese patients with unresectable or recurrent colorectal cancer (CRC). This was a multicenter, single-arm, open-label prospective study.
Autor:
Masahito Kotaka, Hirofumi Kawanaka, Akira Kabashima, Mototsugu Shimokawa, Akitaka Makiyama, Tomomi Kashiwada, Masahiro Hamanoue, Hideo Baba, Keisuke Miwa, Masaki Mori, Eiji Oki, Yuji Miyamoto, Hiroshi Saeki, Yoshito Akagi, Takafumi Ohchi
Publikováno v:
Journal of Clinical Oncology. 37:3548-3548
3548 Background: Elderly patients are often intolerable in combination of cytotoxic agents. Recently, Trifluridine/tipiracil plus bevacizumab has been shown as good candidate for the vulnerable patients. We aimed to assess the efficacy and safety of
Autor:
Yasutaka Baba, Sadao Hayashi, Masahiro Hamanoue, Susumu Hasegawa, Hirohito Tsubouchi, Fumitake Kubo, Y. Baba, Yasuji Komorizono, Masayuki Nakajo, Kazuto Ueno, Shinichi Ueno
Publikováno v:
Oncology Letters. 1:905-911
The present study aimed to retrospectively compare the survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma (HCC). According to our database, derived from th
Autor:
Kenji Tahara, Hirohito Tsubouchi, Yasushi Imamura, Osamu Kubozono, Takuya Hiwaki, Yoshiro Baba, Masahiro Hamanoue, Hirofumi Uto, Yasunari Hiramine, Shigeho Maenohara, Yukihiko Sho
Publikováno v:
Kanzo. 49:113-121
症例は55歳男性,生来健康.平成12年10月吐血のため近医に入院した.上部消化管内視鏡検査で食道静脈瘤破裂を認め,内視鏡的静脈瘤結紮術と内視鏡的硬化療法を受けた.その後,吐血
Autor:
Ryu Ichi Fukuda, Atae Utsunomiya, Kazumasa Ohashi, Manabu Sakamoto, Rie Fukui, Takashi Tsuji, Masahiro Hamanoue, Yuko Nukada, Kensaku Mizuno, Ayako Hayashi, Katsunari Tezuka, Katsuhiko Itoh
Publikováno v:
Proceedings of the National Academy of Sciences. 102:15213-15218
Adult T cell leukemia/lymphoma (ATLL) has been characterized as one of the most aggressive human neoplasias and its incidence is thought to be caused by both genetic and epigenetic alterations to the host cellular genes of T cells infected with human